Skip to main content
SpringerLink
Log in

Workup of New Demyelinating Lesion

  • Chapter
  • First Online:
The Acute Neurology Survival Guide

  • 1820 Accesses

Abstract

An approach to the patient with suspected demyelinating disease including the diagnostic criteria for MS. Overview of the testing to send from the CSF and what imaging will be helpful. Includes a table that differentiates the various demyelinating diseases including multiple sclerosis, neuromyelitis optica, anti-MOG syndrome, and acute demyelinating encephalomyelitis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162–73. https://doi.org/10.1016/S1474-4422(17)30470-2.

    Article  PubMed  Google Scholar 

  2. Bonnan M, Valentino R, Debeugny S, et al. Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders. J Neurol Neurosurg Psychiatry. 2018;89(4):346–51. https://doi.org/10.1136/jnnp-2017-316286.

    Article  PubMed  Google Scholar 

  3. Keegan M, Pineda AA, McClelland RL, Darby CH, Rodriguez M, Weinshenker BG. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology. 2002;58(1):143–6. https://doi.org/10.1212/wnl.58.1.143.

    Article  CAS  PubMed  Google Scholar 

  4. Tillema JM, Pirko I. Neuroradiological evaluation of demyelinating disease. Ther Adv Neurol Disord. 2013;6(4):249–68. https://doi.org/10.1177/1756285613478870.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Brigham and Women’s Hospital, Boston, MA, USA

    Kathryn Holroyd & Kristin Galetta

Authors
  1. Kathryn Holroyd
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kristin Galetta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kristin Galetta .

Editor information

Editors and Affiliations

  1. Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA

    Catherine S.W. Albin

  2. Department of Neurology, Massachusetts General Hospital, Harvard University, Boston, MA, USA

    Sahar F. Zafar

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Holroyd, K., Galetta, K. (2022). Workup of New Demyelinating Lesion. In: Albin, C.S., Zafar, S.F. (eds) The Acute Neurology Survival Guide. Springer, Cham. https://doi.org/10.1007/978-3-030-75732-8_31

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-75732-8_31

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-75731-1

  • Online ISBN: 978-3-030-75732-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation